Cerebral infarction due to embolism of middle cerebral artery
ICD-10 I63.41 is a used to indicate a diagnosis of cerebral infarction due to embolism of middle cerebral artery.
Cerebral infarction due to embolism of the middle cerebral artery (MCA) is a critical condition characterized by the obstruction of blood flow to the MCA, leading to ischemia and subsequent brain tissue death. Clinically, patients may present with sudden onset of neurological deficits, including weakness or paralysis on one side of the body, speech difficulties, and sensory loss. The MCA supplies a significant portion of the lateral cerebral hemisphere, and infarction in this area can result in profound motor and cognitive impairments. The disease progression can vary; some patients may experience transient ischemic attacks (TIAs) before a full-blown stroke, while others may have a rapid decline. Diagnostic considerations include neuroimaging techniques such as CT or MRI to confirm the presence of an infarct and to rule out hemorrhagic stroke. Risk factors for embolism include atrial fibrillation, carotid artery disease, and other cardiovascular conditions that predispose to thrombus formation. Early recognition and intervention are crucial for improving outcomes and minimizing long-term disability.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I63.41 specifically covers cerebral infarction resulting from embolism affecting the middle cerebral artery. This includes embolic strokes due to cardiac sources, such as atrial fibrillation, or from other vascular conditions.
I63.41 should be used when the cerebral infarction is specifically due to embolism of the middle cerebral artery. It is distinct from I63.40, which pertains to thrombosis, and should not be used interchangeably.
Documentation should include clinical findings, imaging results confirming the infarction, and details regarding the embolic source. Notes on the patient's history of cardiovascular disease and risk factors are also critical.
